Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SYF2 is a nuclear protein involved in pre-mRNA splicing as a component of the spliceosome. It plays roles in cell cycle regulation, DNA repair, and is implicated in cancer and neurodegenerative diseases such as ALS. As such it is a potential therapeutic target.
Inhibition of SYF2 function to disrupt splicing, cell cycle progression, and DNA repair
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spliceosome-associated factor SYF2.